1.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: CWRU-AMGN-1198, AMGEN-SCF-980165, NCI-G99-1547
|
|
2.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 to 62 Sponsor: Protocol IDs: UCLA-HSPC-9303106, NCI-V94-0503
|
|
3.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 to 65 Sponsor: Protocol IDs: MSKCC-93060, NCI-V93-0270
|
|
4.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 to 65 Sponsor: Pharmaceutical / Industry Protocol IDs: AMGEN-SCF-950123, NCI-V96-0956
|
|
5.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: RPCI-DS-96-24, NCI-G97-1153
|
|
6.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 to 60 Sponsor: NCI Protocol IDs: NCI-92-C-0161I, NCI-MB-294, NCI-T92-0018N, T92-0018
|
|
7.
|
Phase: Phase II Type: Treatment Status: Completed Age: up to 65 Sponsor: NHLBI Protocol IDs: NHLBI-92-H-57, NCI-T92-0139N, T92-0139
|
|
8.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000067156, FCCC-98052, NCI-G99-1541, NCT00003957
|
|
9.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-96-C-0007K, NCI-MB-361, NCI-T95-0096N, T95-0096
|
|
10.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: RPCI-RP-9911, NCT00058045
|
|
11.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: 06/49, NCT00434239
|